论文部分内容阅读
美国约翰斯·霍普金斯医院的放射肿瘤学家StanleyE Order称,放射性同位素标记抗体治疗原发性肝癌是令人鼓舞的新疗法。一例肝细胞瘤的女病人,瘤重15磅,经此法治疗后,二年内肿瘤缩小到可切除的程度。切除后,处于缓解中。在此地召开的国际癌瘤单克隆抗体免疫结合物会议上,Order总结了105例早期的病例(现在积累的病例已超过200例)。总的说来,他用碘抗铁蛋白抗体治疗后,部分缓解率至少达到48％。
Stanley E Order, a radiation oncologist at Johns Hopkins Hospital in the United States, said that radioactive isotope-labeled antibodies for primary liver cancer are encouraging new treatments. In a female patient with a hepatoma, the tumor weighed 15 pounds. After this treatment, the tumor was reduced to a resectable level within two years. After resection, it is in remission. At the International Conference on Cancer Monoclonal Antibody conjugates held here, Order summarized 105 early cases (more than 200 cases have now been accumulated). Overall, after partial treatment with iodine anti-ferritin antibody, the partial response rate was at least 48%.